Company Description
STERIS plc provides infection prevention products and services worldwide.
It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences.
The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services.
It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services.
The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions.
The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators.
This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services.
It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers.
The company was founded in 1985 and is headquartered in Mentor, Ohio.
| Country | Ireland |
| Founded | 1985 |
| IPO Date | Jun 1, 1992 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 18,179 |
| CEO | Daniel A. Carestio |
Contact Details
Address: 70 Sir John Rogerson's Quay Dublin, L2 2 Ireland | |
| Phone | 35312322000 |
| Website | steris.com |
Stock Details
| Ticker Symbol | STE |
| Exchange | NYSE |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001757898 |
| CUSIP Number | G8473T100 |
| ISIN Number | IE00BFY8C754 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Daniel A. Carestio | President, Chief Executive Officer and Director |
| Michael J. Tokich | Senior Vice President and Chief Financial Officer |
| John Adam Zangerle | Senior Vice President, General Counsel and Secretary |
| Mary Clare Fraser | SVice President and Chief Human Resources Officer |
| Cary L. Majors | Senior Vice President and President of Healthcare |
| Karen L. Burton | Chief Accounting Officer, Vice President and Controller |
| Julie Winter | Vice President of Investor Relations and Corporate Communications |
| Julia K. Madsen | Senior Vice President of Life Sciences |
| Andrew Xilas | Senior Vice President and GM of Dental |
| Kenneth E. Kohler | Senior Vice President and GM of AST |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 21, 2024 | 11-K | Annual report of employee stock purchase, savings and similar plans |
| Jun 12, 2024 | ARS | Filing |
| Jun 12, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 12, 2024 | DEF 14A | Other definitive proxy statements |
| Jun 5, 2024 | 144 | Filing |
| Jun 5, 2024 | 144 | Filing |
| May 31, 2024 | SD | Form - SD |
| May 31, 2024 | 8-K | Current Report |
| May 29, 2024 | 10-K | Annual Report |
| May 21, 2024 | UPLOAD | Filing |